Ceftazidime and avibactam are two anti-infective drugs that can prove difficult to analyze in serum. Determining them can ...

Low levels of resistance have been detected against one of the newest antibiotics, ceftazidime-avibactam, which has been used in the NHS since 2017, the UK Health Security Agency (UKHSA) has warned.

Infectious diseases specialist warns of antibiotic misuse leading to drug resistance, urges strict regulation for newer ...

Antibiotic resistance is believed to be one of the biggest threats to global public health. The UK Health Security Agency (UKHSA) says there were an estimated 66,730 serious antibiotic-resistant ...

Even with more restrictive assumptions, the analysis still showed a substantial treatment gap, with only 14.2% of patients ...

aeruginosa infection can often receive adequate MSSA coverage with antipseudomonal agents (with the exception of ceftazidime and aztreonam). The intravenous options for MRSA are generally limited ...